ABPOOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as ABPWW
Abpro Holdings, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.41+0.00 (+0.11%)
Close on Oct 19, 2026
- Market cap
- $2.41M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Abpro has not reported a dividend
No dividend per share appears in Abpro's annual filings since fiscal 2021.